Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CervoMedSTU:DP8 +0.90%41 Days Inventory is 0.00 as of Jun. 2026. GuruFocus rates STU:DP8 with a GF Score™ of 41/100. The stock has 2 warning signs investors should review. Among 641 Biotechnology companies, CervoMed ranks worse than 156006.08% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). CervoMed's Average Total Inventories for the
three
months ended in Jun. 2026 was €0.00 Mil. CervoMed's Cost of Goods Sold for the
three
months ended in Jun. 2026 was €0.00 Mil.
The historical rank and industry rank for CervoMed's Days Inventory or its related term are showing as below:
STU:DP8's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.69 * Ranked among companies with meaningful Days Inventory only.
CervoMed's Days Inventory
stayed the same
from Jun. 2025 (0.00) to Jun. 2026 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
CervoMed's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CervoMed's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
CervoMed Days Inventory Related Terms
CervoMed Days Inventory Historical Data
* Premium members only.
The historical data trend for CervoMed's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:DP8 vs ACTU, KPTI, ALGS: Days Inventory Comparison
For the Biotechnology subindustry, CervoMed's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CervoMed Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CervoMed's Days Inventory distribution charts can be found below:
* The bar in red indicates where CervoMed's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CervoMed (STU:DP8) has a Days Inventory of 0.00 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CervoMed and its competitors. According to the industry distribution chart, CervoMed ranks #999999 out of 641 companies in the Biotechnology industry.
Is CervoMed's Days Inventory too high?
CervoMed's current Days Inventory is 0.00. Based on the distribution chart, CervoMed ranks #999999 out of 641 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CervoMed has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does CervoMed's Days Inventory compare to ACTU and KPTI?
According to the Biotechnology industry distribution chart, CervoMed ranks #999999 out of 641 companies for Days Inventory. This places CervoMed in the lower half of its industry. The industry median Days Inventory is 183.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.69, based on 641 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on CervoMed and its competitors. For the Biotechnology industry, the median Days Inventory is 183.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CervoMed's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CervoMed stock overvalued right now?
CervoMed (STU:DP8) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. CervoMed's overall GF Score™ is 41/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For CervoMed (STU:DP8), the current Days Inventory is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
41GF Score
Get the complete analysis for STU:DP8
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:DP8 has been successfully added to your 
